We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Private investment firm EQT has increased its offer for Sweden-based Karo Pharma to Skr6.15bn ($694m), partly due to an improved stock market performance since its initial bid more than two months ago......